Russia is ready to sell 100,000,000 doses of Sputnik-V vaccine to India. The country's Direct Investment Fund reported that on September 16.
"Dr Reddy’s, one of India’s top pharmaceutical companies, will carry out Phase III clinical trials of the vaccine in India, pending regulatory approval, RDIF said in a statement. Deliveries to India could begin in late 2020, it said, adding this was subject to the completion of trials and the vaccine’s registration by regulatory authorities in India", reads the story by Reuters.
Unline scientists in Europe and the U.S., the Indian side shows trust for the new vaccine claiming that it "could provide a credible option in our fight against COVID-19 in India", as G.V. Prasad, co-chairman of Dr Reddy’s put it.
Currently, the number of Covid-19 cases registered in India exceeded five million.